Literature DB >> 17047113

An exuberant inflammatory response to E coli: implications for the pathogenesis of ulcerative colitis and pyoderma gangrenosum.

D J B Marks, F Z Rahman, M Novelli, R C Yu, S McCartney, S Bloom, A W Segal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17047113      PMCID: PMC1860126          DOI: 10.1136/gut.2006.104943

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  Cantharidin blisters: a technique for investigating leukocyte trafficking and cytokine production at sites of inflammation in humans.

Authors:  R M Day; M Harbord; A Forbes; A W Segal
Journal:  J Immunol Methods       Date:  2001-11-01       Impact factor: 2.303

2.  Defective acute inflammation in Crohn's disease: a clinical investigation.

Authors:  Daniel J B Marks; Marcus W N Harbord; Raymond MacAllister; Farooq Z Rahman; Jodi Young; Bissan Al-Lazikani; William Lees; Marco Novelli; Stuart Bloom; Anthony W Segal
Journal:  Lancet       Date:  2006-02-25       Impact factor: 79.321

Review 3.  Pyoderma gangrenosum: a review.

Authors:  A Neil Crowson; Martin C Mihm; Cynthia Magro
Journal:  J Cutan Pathol       Date:  2003-02       Impact factor: 1.587

4.  Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation.

Authors:  Darshna R Yagnik; Betsy J Evans; Oliver Florey; Justin C Mason; R Clive Landis; Dorian O Haskard
Journal:  Arthritis Rheum       Date:  2004-07

5.  'Sticky' neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis.

Authors:  A D Dwarakanath; L G Yu; C Brookes; D Pryce; J M Rhodes
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

  5 in total
  7 in total

1.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315

2.  Delayed resolution of acute inflammation in ulcerative colitis is associated with elevated cytokine release downstream of TLR4.

Authors:  Farooq Z Rahman; Andrew M Smith; Bu'Hussain Hayee; Daniel J B Marks; Stuart L Bloom; Anthony W Segal
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

Review 3.  Crohn's disease: an immune deficiency state.

Authors:  Daniel J B Marks; Farooq Z Rahman; Gavin W Sewell; Anthony W Segal
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

4.  Treatment of inflammatory bowel disease associated E. coli with ciprofloxacin and E. coli Nissle in the streptomycin-treated mouse intestine.

Authors:  Andreas Munk Petersen; Susanne Schjørring; Sarah Choi Gerstrøm; Karen Angeliki Krogfelt
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

5.  Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases.

Authors:  Andreas Munk Petersen
Journal:  APMIS       Date:  2022-08       Impact factor: 3.428

6.  Dysregulation of human beta-defensin-2 protein in inflammatory bowel disease.

Authors:  Marian C Aldhous; Colin L Noble; Jack Satsangi
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

7.  A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease.

Authors:  Andreas M Petersen; Eva M Nielsen; Eva Litrup; Jørn Brynskov; Hengameh Mirsepasi; Karen A Krogfelt
Journal:  BMC Microbiol       Date:  2009-08-20       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.